ReviewFrontiers in psychiatry2026
Psychosexual burden in adult genital psoriasis: outcome measurement, construct coverage, and clinical recognition gaps.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult genital psoriasis is associated with local symptoms and effects on sexual activity, intimate relationships, body exposure, and patient communication. The associated psychosexual burden is not adequately summarized by lesion severity or sexual function scores alone. This integrative review examines outcome measurement, construct coverage, and clinical recognition of psychosexual burden in adult genital psoriasis. Existing measurement tools and related measurement approaches capture several relevant components, including genital-site severity, local symptoms, sexual activity-related impact, sexual function, quality of life, sexual health-related quality of life, genital self-image, sexual distress, and selected communication or care needs. These tools and approaches differ in measurement targets, assessment perspectives, applicable populations, scoring assumptions, and contexts of use. They therefore do not readily provide a complete representation of psychosexual burden. This review uses four candidate domains-symptom experience, sexual and intimacy-related impact, psychological and self-presentation burden, and communication and care needs-to compare construct coverage across existing tools. Sexual function scores provide information on sexual response and functional status, but do not substitute for identifying sexual distress, sexual avoidance, genital self-image, self-presentation burden, or communication needs. Even when related burden is recorded in research instruments, it does not necessarily gain clinical visibility in routine dermatology practice. To address this clinical recognition gap, this review proposes a brief, non-diagnostic, low-burden communication entry point that serves as a conceptual starting point for initial discussion, documentation, and future evaluation of psychosexual concerns in routine dermatology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.